Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Uveitis, Uveitis, Posterior, Uveitis, Intermediate
In brief
A study to evaluate the safety and efficacy of a fluocinolone acetonide intravitreal (FAI) insert in the management of subjects with chronic non-infectious uveitis affecting the posterior segment of the eye.
Key facts
- Study ID
- NCT05070728
- Run by
- EyePoint Pharmaceuticals, Inc.
- People needed
- 12
- Starts
- 2021-10-13
- Expected to finish
- 2023-04-12
- Last updated by the study team
- 2024-12-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- EyePoint Study Site — Waltham, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.